Skip to content

Medical-device intelligence

JBQ: Antithrombin Iii Quantitation

FDA product code JBQ: Antithrombin Iii Quantitation. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JBQ
FDA device name
Antithrombin Iii Quantitation
Device class
2
Regulation number
864.7060
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

56 clearance records and 0 recall records in the covered releases, across 40 source company names and 1 product codes. Dated history runs from Mar 30, 1977 to Mar 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JBQ · Antithrombin Iii Quantitation560

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

56 matching records
Device / recordCompany in FDA recordSourceSource date
COACUTE ANTITHROMBIN CHROMOGENIC ASSAYK902393 · JBQKabi Diagnostica510(k)Sep 25, 1990FDA decision date
SPECTROLYSE ATIII KITK902530 · JBQBiopool AB510(k)Aug 9, 1990FDA decision date
BECKMAN ANTITHROMBIN III REAGENT KITK901977 · JBQBeckman Instruments, Inc.510(k)Aug 6, 1990FDA decision date
ORTHOKROME* ANTITHROMBINK900400 · JBQOrtho Diagnostic Systems, Inc.510(k)Mar 15, 1990FDA decision date
ACTICHROME ATIII KITK893608 · JBQAmerican Diagnostic Corp.510(k)Jun 23, 1989FDA decision date
TURBOX ANTITHROMBIN IIIK884144 · JBQUnipath , Ltd.510(k)Dec 20, 1988FDA decision date
BERICHROM(R) ANTITHROMBIN IIIK883662 · JBQBehring Diagnostics, Inc.510(k)Nov 23, 1988FDA decision date
ENZYGNOST(R) TAT REAGENTSK880700 · JBQBehring Diagnostics, Inc.510(k)Apr 27, 1988FDA decision date
DADE ANTITHROMBIN III CHROMOGENIC ASSAYK880315 · JBQBaxter Healthcare Corp510(k)Mar 16, 1988FDA decision date
IL TEST 97574-15M, ANTITTHROMBIN III ASSASYK864214 · JBQInstrumentation Laboratory CO510(k)Nov 25, 1986FDA decision date
GEN. DIAG. CHROMOSTRATE ANTITHROMBIN III ASSAYK850412 · JBQWarner-Lambert Co.510(k)May 8, 1985FDA decision date
IL TEST ANTITHROMBIN III ACTIVITYK841736 · JBQInstrumentation Laboratory CO510(k)Sep 6, 1984FDA decision date
DIACROM * ATIIIK832592 · JBQWellcome Diagnostics510(k)Sep 29, 1983FDA decision date
RABBIT ANTI-HUMAN ANTITHROMBIN IIIK832268 · JBQGelco Diagnostics, Inc.510(k)Aug 12, 1983FDA decision date
IMMUNODIFFUSION TEST HUMAN ANTITHROMBINK831961 · JBQKent Laboratories, Inc.510(k)Aug 11, 1983FDA decision date
PROTOTRO/PROTEOLYTIC ENZYME CONTROLK831297 · JBQAmerican Dade510(k)Jun 8, 1983FDA decision date
COATEST ANTITHROMBINK812829 · JBQKabivitrum, Inc.510(k)Dec 30, 1981FDA decision date
ACA ANTITHROMBIN III PLASMINOGEN CALIBK812626 · JBQE.I. Dupont DE Nemours & Co., Inc.510(k)Nov 24, 1981FDA decision date
ACA ANTITHROMBIN III TEST PACKK812627 · JBQE.I. Dupont DE Nemours & Co., Inc.510(k)Oct 8, 1981FDA decision date
ANTITHROMBIN III SCREEN KITK812215 · JBQPacific Hemostasis510(k)Sep 1, 1981FDA decision date
HELENA AT-III QUIPLATE PROCEDUREK802912 · JBQHelena Laboratories510(k)Dec 22, 1980FDA decision date
PHADECODE XA INHIBITOR ASSAYK792019 · JBQPharmaseal Div., Baxter Healthcare Corp.510(k)Nov 5, 1979FDA decision date
DETERMINATION OF ANTITHROMBIN III, 885K790090 · JBQSigma Chemical Co.510(k)Feb 26, 1979FDA decision date
ASSAY, CHROMOGENIC ANTITHROMBIN IIIK781860 · JBQOrtho Diagnostics, Inc.510(k)Dec 4, 1978FDA decision date
ANTITHROMBIN III ASSAYK781480 · JBQDade, Baxter Travenol Diagnostics, Inc.510(k)Nov 8, 1978FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗